DNAiTECH Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $619K

  • Investors
  • 4

DNAiTECH General Information

Description

Operator of a biotechnology company intended for developing innovative point-of-care (POC) diagnostics systems. The company aims to meet the challenge of POC testing, fulfilling the World Health Organization's criteria and delivering rapid, robust molecular tests for use beyond the laboratory, enabling clients to utilize a portable DNA amplification system.

Contact Information

Website
www.dnaitech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Marlborough Research Center
  • 2650 State Highway 1, Grovetown, Marlborough
  • Blenheim, 7202
  • New Zealand
+64 021
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Marlborough Research Center
  • 2650 State Highway 1, Grovetown, Marlborough
  • Blenheim, 7202
  • New Zealand
+64 021

DNAiTECH Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DNAiTECH Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 21-Oct-2024 $619K Completed Generating Revenue
1. Accelerator/Incubator 09-May-2024 Completed Startup
To view DNAiTECH’s complete valuation and funding history, request access »

DNAiTECH Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

DNAiTECH Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2026902859-A0 Biomolecular assay apparatus, chip and methods for combined biomolecule isothermal amplification and molecular diagnostics. Pending 31-Mar-2026
WO-2026197917-A1 Biomolecular assay systems and methods for biomolecule isothermal amplification Pending 21-Mar-2025

DNAiTECH Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DNAiTECH Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Finistere Ventures Venture Capital Minority
Fonterra Co-operative Group Corporation Minority
OurCrowd Venture Capital Minority
Sprout Agritech Accelerator/Incubator Minority
To view DNAiTECH’s complete investors history, request access »

Ready to get started?

Request a free trial

DNAiTECH FAQs

  • When was DNAiTECH founded?

    DNAiTECH was founded in 2019.

  • Where is DNAiTECH headquartered?

    DNAiTECH is headquartered in Blenheim, New Zealand.

  • What is the size of DNAiTECH?

    DNAiTECH has 3 total employees.

  • What industry is DNAiTECH in?

    DNAiTECH’s primary industry is Biotechnology.

  • Is DNAiTECH a private or public company?

    DNAiTECH is a Private company.

  • What is DNAiTECH’s current revenue?

    The current revenue for DNAiTECH is .

  • How much funding has DNAiTECH raised over time?

    DNAiTECH has raised $619K.

  • Who are DNAiTECH’s investors?

    Finistere Ventures, Fonterra Co-operative Group, OurCrowd, and Sprout Agritech have invested in DNAiTECH.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process